Clinical Trial Update: Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and efficacy of L19TNF in IDH-wildtype WHO grade III/IV glioma at first relapse (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma of Brain

Drugs mentioned

• L19TNF

Snippet

Sponsor: Philogen S.p.A. | Conditions: Glioma of Brain | Phase 1, Phase 2 | Status: COMPLETED